The latest update is out from Kissei Pharmaceutical Co ( (JP:4547) ).

MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has relaunched ORGOVYX ® ...

Credit: Getty Images. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations. Although a recent meta-analysis suggested that ...

Reports suggest that at least 25% of ovarian disorders are due to dysfunction of the brain mechanism in the hypothalamus that controls the gonadotropin-releasing hormone (GnRH), which is a molecule ...

May 11, 2011 — Gonadotropin-releasing hormone (GnRH) antagonists give similar live-birth rates as GnRH agonists but with markedly lower incidence of severe ovarian hyperstimulation syndrome (OHSS), ...

In 1977, the Nobel Prize in Physiology or Medicine was awarded to Roger Guillemin and Andrew Schally for their discovery and synthesis of gonadotropin-releasing hormone (GnRH), a key regulator of ...

Abstract: Immunocontraceptive vaccines based on gonadotropin-releasing hormone (GnRH) have been tested in adult white-tailed deer (Odocoileus virginianus), but their effects on fawns are unknown. The ...

Treating Heavy Menstrual Bleeding: What's Best? Menometrorrhagia-excessive and prolonged uterine bleeding at irregular or frequent intervals [1] —is most often caused by uterine fibroids, and symptom ...

Two Sealed Airtight Medical Vials Against Bright Background Front View. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations.